ATE311208T1 - Verwendung von hyaluonsäurederivaten zur herstellung von biomaterial - Google Patents

Verwendung von hyaluonsäurederivaten zur herstellung von biomaterial

Info

Publication number
ATE311208T1
ATE311208T1 AT98945104T AT98945104T ATE311208T1 AT E311208 T1 ATE311208 T1 AT E311208T1 AT 98945104 T AT98945104 T AT 98945104T AT 98945104 T AT98945104 T AT 98945104T AT E311208 T1 ATE311208 T1 AT E311208T1
Authority
AT
Austria
Prior art keywords
acid derivatives
hyaluonic
producing biomaterial
formation
biomaterial
Prior art date
Application number
AT98945104T
Other languages
English (en)
Inventor
Alberto Rivarossa
Daniele Pressato
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Application granted granted Critical
Publication of ATE311208T1 publication Critical patent/ATE311208T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT98945104T 1997-07-28 1998-07-28 Verwendung von hyaluonsäurederivaten zur herstellung von biomaterial ATE311208T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97PD000170A IT1294797B1 (it) 1997-07-28 1997-07-28 Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante
PCT/EP1998/004716 WO1999004828A2 (en) 1997-07-28 1998-07-28 Use of hyaluronic acid derivatives in the preparation of biomaterials

Publications (1)

Publication Number Publication Date
ATE311208T1 true ATE311208T1 (de) 2005-12-15

Family

ID=11391877

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98945104T ATE311208T1 (de) 1997-07-28 1998-07-28 Verwendung von hyaluonsäurederivaten zur herstellung von biomaterial

Country Status (13)

Country Link
US (1) US7202230B2 (de)
EP (1) EP0999859B1 (de)
JP (1) JP4417547B2 (de)
AT (1) ATE311208T1 (de)
AU (1) AU749627B2 (de)
CA (1) CA2298733C (de)
DE (1) DE69832616T2 (de)
DK (1) DK0999859T3 (de)
ES (1) ES2253827T3 (de)
HK (1) HK1028210A1 (de)
IL (2) IL134140A0 (de)
IT (1) IT1294797B1 (de)
WO (1) WO1999004828A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306679B1 (it) * 1999-06-29 2001-10-02 Fidia Advanced Biopolymers Srl Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della
AU2001266926A1 (en) * 2000-06-16 2002-01-02 University Of Medicine And Dentistry Of New Jersey Hemostatic compositions, devices and methods
US7094428B2 (en) 2000-06-16 2006-08-22 The University Of Medicine And Dentistry Of New Jersey Hemostatic compositions, devices and methods
US6235796B1 (en) * 2000-06-26 2001-05-22 Sarfaraz K. Niazi Use of fluorocarbons for the prevention of surgical adhesions
WO2005010080A1 (ja) * 2003-07-28 2005-02-03 Teijin Limited 温度応答性ハイドロゲル
DE10349722A1 (de) * 2003-10-23 2005-06-16 Beschorner, Katharina, Dr. Zusammensetzung zur Arthrose-/Arthritisbehandlung, insbesondere von Gelenken
JP4959557B2 (ja) * 2004-07-09 2012-06-27 フェロサン メディカル デバイシーズ エイ／エス ヒアルロン酸含有止血合成剤
ITPD20040245A1 (it) * 2004-10-08 2005-01-08 Fidia Advanced Biopolymers Srl Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali
EP1833517B1 (de) * 2004-12-14 2008-09-24 Fidia Advanced Biopolymers S.R.L. Verfahren zur herstellung von zwei- und dreidimensionalen polymergerüsten
ITPD20040312A1 (it) * 2004-12-15 2005-03-15 Fidia Advanced Biopolymers Srl Protesi e o supporto per la sostituzione, riparazione, rigenerazione del menisco
ITPD20050206A1 (it) * 2005-07-07 2007-01-08 Fidia Advanced Biopolymers Srl Biomateriali in forma di fibra da impiegarsi come dispositivi medici nel trattamento delle ferite e loro processi di produzione
ITMI20051415A1 (it) * 2005-07-22 2007-01-23 Fidia Advanced Biopolymers Srl Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione
JP2009529374A (ja) * 2006-03-07 2009-08-20 アクスル インターナショナル 治療及び癒着防止用生物活性スキャホールド
ITPD20060219A1 (it) * 2006-05-31 2007-12-01 Fidia Farmaceutici Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
EP2281008B1 (de) 2008-04-04 2017-01-04 University of Utah Research Foundation Alkylierte und sulfatierte hyaluronsäure, verfahren zu ihrer herstellung und ihre verwendung
US8343942B2 (en) 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
TWI458833B (zh) 2010-05-11 2014-11-01 Univ China Medical 奈米金屬分散液及其製法
AU2012230822A1 (en) 2011-03-23 2013-11-07 University Of Utah Research Foundation Methods for treating or preventing urological inflammation
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
CN104349797B (zh) 2012-06-12 2017-10-27 弗罗桑医疗设备公司 干止血组合物
CA2912357C (en) 2013-06-21 2019-12-31 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
HRP20220176T1 (hr) 2014-02-27 2022-04-29 Synartro Ab Konjugati hijaluronana s farmaceutski aktivnim tvarima, postupci i pripravci
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
CN107771093B (zh) 2015-07-03 2021-06-15 弗罗桑医疗设备公司 用于混合两种组分和用于在存储条件下保持真空的注射器
KR20180027126A (ko) * 2016-09-06 2018-03-14 (주)한국비엠아이 가교화 히알루론산 유도체 매트릭스가 포함된 지혈 조성물
US11337994B2 (en) 2016-09-15 2022-05-24 University Of Utah Research Foundation In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
JP7395113B2 (ja) 2018-05-09 2023-12-11 フェロサン メディカル デバイシーズ エイ／エス 止血組成物を調製する方法
KR101980063B1 (ko) * 2019-01-25 2019-05-17 주식회사 휴메딕스 히알루론산을 포함하는 스펀지형 생분해성 지혈제 조성물
CN113754795B (zh) * 2021-10-19 2023-03-10 澳门大学 磺酸化透明质酸类化合物、其制备方法及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US5202431A (en) 1985-07-08 1993-04-13 Fidia, S.P.A. Partial esters of hyaluronic acid
IT1203814B (it) 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
GB8911177D0 (en) * 1989-05-16 1989-07-05 Vilain Jean Alginate gel pharmaceutical product
IT1247157B (it) 1991-02-11 1994-12-12 Fidia Spa Canali di guida biodegradabili e bioassorbibili da impiegare per la rigenerazione nervosa.
US5332809A (en) 1991-02-11 1994-07-26 Fidia S.P.A. Partial esters of gellan
GB9109367D0 (en) * 1991-05-01 1991-06-26 Merck Sharp & Dohme Surgical dressing
IT1247472B (it) 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
IT1254704B (it) 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
IT1264322B (it) 1992-07-30 1996-09-23 Lanfranco Callegaro Esteri di gellano autoreticolato, procedimento di preparazione e loro applicazioni farmaceutiche e biomedico-sanitarie
IT1259141B (it) 1992-08-03 1996-03-11 Fidia Spa Canali di guida biodegradabili e bioriassorbibili da impiegare per la riparazione tissutale come adiuvante in interventi chirurgici
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
FR2723847A1 (fr) * 1994-08-29 1996-03-01 Debiopharm Sa Compositions antithrombotiques et non hemorragiques a base d'heparine, procede pour leur preparation et applications therapeutiques.
IT1281877B1 (it) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici
GB9514361D0 (en) * 1995-07-13 1995-09-13 Bristol Myers Squibb Co A film for topical use in the treatment of wounds
CN1301139C (zh) * 1995-08-29 2007-02-21 菲迪亚高级生物聚合物公司 包括透明质酸衍生物的用于预防手术后粘连的生物材料
IT1282994B1 (it) * 1996-05-10 1998-04-03 Inalco Spa Derivati del polisaccaride k5 aventi elevata attivita' anticoagulante
IT1287698B1 (it) 1996-08-29 1998-08-18 Fidia Advanced Biopolymers Srl Fili da sutura essenzialmente costituiti da derivati esterei dello acido ialuronico

Also Published As

Publication number Publication date
AU749627B2 (en) 2002-06-27
US7202230B2 (en) 2007-04-10
EP0999859B1 (de) 2005-11-30
WO1999004828A2 (en) 1999-02-04
JP2001510713A (ja) 2001-08-07
US20030060448A1 (en) 2003-03-27
DE69832616D1 (de) 2006-01-05
ITPD970170A1 (it) 1999-01-28
ES2253827T3 (es) 2006-06-01
AU9255598A (en) 1999-02-16
CA2298733A1 (en) 1999-02-04
IL134140A0 (en) 2001-04-30
DK0999859T3 (da) 2006-03-27
IT1294797B1 (it) 1999-04-15
IL134140A (en) 2006-08-20
CA2298733C (en) 2009-09-01
HK1028210A1 (en) 2001-02-09
WO1999004828A3 (en) 1999-06-10
DE69832616T2 (de) 2006-08-17
EP0999859A2 (de) 2000-05-17
JP4417547B2 (ja) 2010-02-17

Similar Documents

Publication Publication Date Title
ATE311208T1 (de) Verwendung von hyaluonsäurederivaten zur herstellung von biomaterial
JP3446101B2 (ja) 組織治療用組成物
Brochhausen et al. Intraperitoneal adhesions—an ongoing challenge between biomedical engineering and the life sciences
FI942895A (fi) Kudosten ohjattuun regenerointiin tarkoitetut yhdistelmämateriaalikalvot
EP0956869A3 (de) Gewebeklebstoff
AU573626B2 (en) Protein/polysaccharide complexes as wound dressing
ATE390152T1 (de) Dezellularisierte gefässprothesen
Smith et al. AV anastomosis as a solution for absent venous drainage in replantation surgery
DE69429878D1 (de) Resorbierbarer gefässwundenverband
ATE200630T1 (de) Verbundvliesstoff, enthaltend derivate von hyaluronsäure
HK1047404A1 (en) Vascular coating composition
DE59609340D1 (de) Beschichtung für in den blutstrom oder in das gewebe des menschlichen körpers einbringbares biomaterial
DE69528654T2 (de) Anti-adhäsionsmittel
RU97102350A (ru) Анти-адгезионный агент
DK1085917T3 (da) Biomaterialer indeholdende hyaluronsyrederivater i form af tredimensionale strukturer, som er frie for cellulære komponenter eller produkter deraf, til in vivo-regenerering af vævsceller
WO2001035996A3 (en) Use of pdt to inhibit intimal hyperplasia
SE1950885A1 (en) Treatment of patients undergoing antiplatelet medication experiencing acute bleeding complications during / after surgery
Upton et al. Acquired arteriovenous fistulas in children
ATE222501T1 (de) Tissue-faktor zur beeinflussung von gefässbildung
Li et al. Peptide‐coated vascular grafts: an in vivo study in sheep
Gyurkó et al. Experiences obtained with polyester velour angioplasty
EP1782849A3 (de) Dreidimensionales Bindegewebe
Konrad et al. Caution advised in using collagen clinically

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0999859

Country of ref document: EP